InvestorsHub Logo

lorema

09/20/18 8:19 AM

#1911 RE: biotechexpert #1910

No, it has to be a reduction on at least 20% from baseline.

Inoviorulez

09/20/18 6:00 PM

#1916 RE: biotechexpert #1910

No. it would have to be higher from control. stat sig. although placebo doesn't do anything in respect to HVPG.

In essence in the pilot study

8 out of 12 patients achieved a > 10% reduction

and 4 out of 12 patients achieved a >20% reduction.

So the company chose to only recruit patients with over 12 mmHg (mercury) meaning severe portal hypertension.